These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6091392)

  • 1. Misonidazole neuropathy.
    Paulson OB; Melgaard B; Hansen HS; Kamieniecka Z; Køhler O; Hansen JM; Pedersen AG; Tang X; Trojaborg W
    Acta Neurol Scand Suppl; 1984; 100():133-6. PubMed ID: 6091392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Misonidazole Neuropathy: a clinical, electrophysiological, and histological study.
    Melgaard B; Hansen HS; Kamieniecka Z; Paulson OB; Pedersen AG; Tang X; Trojaborg W
    Ann Neurol; 1982 Jul; 12(1):10-7. PubMed ID: 7114817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Misonidazole neuropathy. A prospective study.
    Melgaard B; Køhler O; Sand Hansen H; Overgaard J; Munck-Hansen J; Paulson OB
    J Neurooncol; 1988 Nov; 6(3):227-30. PubMed ID: 3066854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electroneurographic investigations of misonidazole polyneuropathy.
    Mamoli B; Wessely P; Kogelnik HD; Müller M; Rathkolb O
    Eur Neurol; 1979; 18(6):405-14. PubMed ID: 232682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Misonidazole peripheral neuropathy: its relationship to plasma concentration and other drugs.
    Walker MD; Strike TA
    Cancer Clin Trials; 1980; 3(2):105-9. PubMed ID: 6253094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral neuropathy related to misonidazole: incidence and pathology.
    Urtasun RC; Chapman JD; Feldstein ML; Band RP; Rabin HR; Wilson AF; Marynowski B; Starreveld E; Shnitka T
    Br J Cancer Suppl; 1978 Jun; 3():271-5. PubMed ID: 209809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma concentration of misonidazole and peripheral neuropathy.
    Marten TR
    Am J Clin Oncol; 1982 Apr; 5(2):239-40. PubMed ID: 6283876
    [No Abstract]   [Full Text] [Related]  

  • 8. Dose-response curves for predicting misonidazole-induced peripheral neuropathy.
    Schwade JG; Makuch RW; Strong JM; Glatstein E
    Cancer Treat Rep; 1982 Sep; 66(9):1743-50. PubMed ID: 6288238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of the effect of misonidazole in conjunction with radiotherapy for the treatment of head and neck cancer. MRC working party on misonidazole in head and neck cancer.
    Br J Radiol; 1984 Jul; 57(679):585-95. PubMed ID: 6329395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Misonidazole combined with radiotherapy in the treatment of inoperable squamous cell carcinoma of the lung. A double-blind randomized trial.
    Panduro J; Kjaer M; Wolff-Jensen J; Hansen HH
    Cancer; 1983 Jul; 52(1):20-4. PubMed ID: 6303553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neurotoxicity of misonidazole: pooling of data from five centres.
    Disch S; Saunders MI; Anderson P; Urtasun RC; Karcher KH; Kogelnik HD; Bleehen N; Phillips TL; Wasserman TH
    Br J Radiol; 1978 Dec; 51(612):1023-4. PubMed ID: 216455
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical experience with misonidazole: high dose fractions versus daily low doses.
    Kogelnik HD
    Cancer Clin Trials; 1980; 3(2):179-86. PubMed ID: 6253098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neurotoxicity of misonidazole and its relationship to dose, half-life and concentration in the serum.
    Saunders ME; Dische S; Anderson P; Flockhart IR
    Br J Cancer Suppl; 1978 Jun; 3():268-70. PubMed ID: 209808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Misonidazole combined with split-course radiotherapy in the treatment of invasive carcinoma of larynx and pharynx: report from the DAHANCA 2 study.
    Overgaard J; Hansen HS; Andersen AP; Hjelm-Hansen M; Jørgensen K; Sandberg E; Berthelsen A; Hammer R; Pedersen M
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1065-8. PubMed ID: 2649462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of microsomal enzyme inducers in the reduction of misonidazole neurotoxicity.
    Jones DH; Bleehen NM; Workman P; Smith NC
    Br J Radiol; 1983 Nov; 56(671):865-70. PubMed ID: 6626878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurotoxicity of Adriamycin and misonidazole in the mouse.
    Boegman RJ; Scarth B; Dragovic L; Robertson DM
    Exp Neurol; 1985 Jan; 87(1):1-8. PubMed ID: 2981696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurotoxicity with desmethylmisonidazole.
    Dische S; Saunders MI; Stratford MR
    Br J Radiol; 1981 Feb; 54(638):156-7. PubMed ID: 6257319
    [No Abstract]   [Full Text] [Related]  

  • 18. The neurotoxicity of misonidazole: potential modifying role of phenytoin sodium and dexamethasone.
    Wasserman TH; Phillips TL; Van Raalte G; Urtasun R; Partington J; Koziol D; Schwade JG; Gangji D; Strong JM
    Br J Radiol; 1980 Feb; 53(626):172-3. PubMed ID: 6245744
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical evaluation of hypoxic cell sensitizer (Misonidazole)].
    Asakawa H; Watarai J; Hoshino T
    Gan To Kagaku Ryoho; 1984 Jun; 11(6):1225-30. PubMed ID: 6732250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience in the radical radiotherapy of cancer in the bilharzial bladder: the use of misonidazole.
    Awwad HK; Akhoush H; El-Merzabani M; El Badawy S; Barsoum M; el Baki HA
    Radiother Oncol; 1984 Jun; 2(1):1-8. PubMed ID: 6095372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.